Apretude

Apretude (cabotegravir) is a prescription medicine used for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (at least 35 kg). APRETUDE is given every other month by a healthcare provider after initiation injections have been given 1 month apart for 2 consecutive months.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.